Scientific Advisory Board – PsiVac
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Cancer: Scientists aim to double survival within a decade | The Independent
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
RM Magazine - spring 2012 - The Royal Marsden
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Professor Kevin Harrington | The Royal Marsden
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington | Oncologist in Sutton - Doctify
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Kevin Harrington, PhD on KEYNOTE-048: What Is The Second-...
Professor Kevin Harrington - News, Articles etc. - European Pharmaceutical Review
Kevin Harrington (@kevhar6763) / Twitter
Professor Kevin Harrington - The Institute of Cancer Research, London
Descifrando la complejidad clínica del cáncer de cabeza y cuello – Fundación ECO para la Excelencia y Calidad en la Oncología
Potential of immunotherapy in head and neck cancer | VJOncology
Potential of immunotherapy in head and neck cancer | VJOncology
